tiprankstipranks
Suven Pharmaceuticals Ltd. (IN:COHANCE)
:COHANCE
India Market
COHANCE
Suven Pharmaceuticals Ltd.
RESEARCH TOOLSreports

Suven Pharmaceuticals Ltd. (COHANCE) Ratios

2 Followers

Suven Pharmaceuticals Ltd. Ratios

IN:COHANCE's free cash flow for Q2 2026 was ₹0.75. For the 2026 fiscal year, IN:COHANCE's free cash flow was decreased by ₹ and operating cash flow was ₹0.17. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 2.92 2.43 11.82 6.37 5.36
Quick Ratio
 1.98 1.98 9.65 4.40 4.02
Cash Ratio
 0.13 0.23 0.44 0.41 0.21
Solvency Ratio
 0.20 0.29 1.74 1.99 1.63
Operating Cash Flow Ratio
 0.41 0.79 3.35 2.84 1.57
Short-Term Operating Cash Flow Coverage
 1.76 4.01 9.29 6.98 4.92
Net Current Asset Value
₹ 2.01B₹ -3.03B₹ 10.60B₹ 7.80B₹ 8.26B
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.09 0.03 0.04 0.05
Debt-to-Equity Ratio
 0.12 0.16 0.03 0.04 0.06
Debt-to-Capital Ratio
 0.11 0.14 0.03 0.04 0.06
Long-Term Debt-to-Capital Ratio
 0.02 <0.01 0.00 <0.01 0.02
Financial Leverage Ratio
 1.47 1.79 1.10 1.13 1.20
Debt Service Coverage Ratio
 1.96 3.87 7.87 6.10 6.09
Interest Coverage Ratio
 14.65 45.80 61.84 40.50 64.24
Debt to Market Cap
 0.02 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 18.90 11.36 2.85 3.27 4.15
Net Debt to EBITDA
 0.89 0.48 0.04 <0.01 0.08
Profitability Margins
Gross Profit Margin
68.19%68.63%57.34%56.32%56.96%
EBIT Margin
13.95%27.40%39.29%42.72%49.23%
EBITDA Margin
20.28%33.87%44.49%46.28%52.26%
Operating Profit Margin
24.13%47.23%43.83%38.71%41.99%
Pretax Profit Margin
11.64%28.72%38.59%41.76%51.76%
Net Profit Margin
9.83%22.37%28.56%30.69%35.18%
Continuous Operations Profit Margin
8.80%22.11%28.56%30.69%32.00%
Net Income Per EBT
84.48%77.89%74.02%73.48%67.98%
EBT Per EBIT
48.22%60.80%88.04%107.89%123.26%
Return on Assets (ROA)
3.62%8.84%13.32%20.92%24.80%
Return on Equity (ROE)
8.63%15.79%14.64%23.70%29.72%
Return on Capital Employed (ROCE)
10.03%21.21%21.46%28.71%33.45%
Return on Invested Capital (ROIC)
7.33%15.72%15.57%20.36%21.82%
Return on Tangible Assets
4.78%11.58%13.70%21.61%24.83%
Earnings Yield
2.08%0.97%1.76%3.42%2.88%
Efficiency Ratios
Receivables Turnover
 3.40 4.20 7.87 12.08 5.42
Payables Turnover
 2.08 4.68 10.59 12.00 5.24
Inventory Turnover
 1.10 2.26 1.94 1.87 1.96
Fixed Asset Turnover
 0.97 0.96 1.34 1.75 2.30
Asset Turnover
 0.37 0.40 0.47 0.68 0.70
Working Capital Turnover Ratio
 3.38 1.43 1.05 1.51 2.04
Cash Conversion Cycle
 263.75 170.71 200.08 194.83 184.04
Days of Sales Outstanding
 107.37 86.81 46.40 30.21 67.31
Days of Inventory Outstanding
 331.59 161.82 188.15 195.03 186.36
Days of Payables Outstanding
 175.22 77.92 34.47 30.41 69.64
Operating Cycle
 438.97 248.63 234.55 225.24 253.67
Cash Flow Ratios
Operating Cash Flow Per Share
 10.18 11.24 14.09 17.71 12.96
Free Cash Flow Per Share
 6.68 5.16 12.05 6.49 10.01
CapEx Per Share
 3.50 6.07 2.04 11.23 2.95
Free Cash Flow to Operating Cash Flow
 0.66 0.46 0.86 0.37 0.77
Dividend Paid and CapEx Coverage Ratio
 2.91 1.85 6.92 0.92 1.86
Capital Expenditure Coverage Ratio
 2.91 1.85 6.92 1.58 4.39
Operating Cash Flow Coverage Ratio
 0.58 1.03 5.52 6.41 3.40
Operating Cash Flow to Sales Ratio
 0.13 0.24 0.34 0.34 0.26
Free Cash Flow Yield
1.19%0.48%1.80%1.37%1.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 48.05 102.82 56.75 29.24 34.69
Price-to-Sales (P/S) Ratio
 7.05 23.00 16.21 8.97 12.21
Price-to-Book (P/B) Ratio
 2.56 16.23 8.31 6.93 10.31
Price-to-Free Cash Flow (P/FCF) Ratio
 84.33 207.95 55.57 72.82 61.78
Price-to-Operating Cash Flow Ratio
 37.11 95.58 47.54 26.67 47.71
Price-to-Earnings Growth (PEG) Ratio
 -2.56 -9.48 -2.10 -3.12 1.37
Price-to-Fair Value
 2.56 16.23 8.31 6.93 10.31
Enterprise Value Multiple
 35.64 68.39 36.47 19.40 23.44
Enterprise Value
 148.25B 277.37B 170.60B 120.31B 157.96B
EV to EBITDA
 35.64 68.39 36.47 19.40 23.44
EV to Sales
 7.23 23.16 16.23 8.98 12.25
EV to Free Cash Flow
 86.48 209.42 55.62 72.85 61.99
EV to Operating Cash Flow
 56.77 96.26 47.59 26.68 47.87
Tangible Book Value Per Share
 100.26 43.74 78.15 65.72 59.90
Shareholders’ Equity Per Share
 147.70 66.16 80.58 68.16 59.99
Tax and Other Ratios
Effective Tax Rate
 0.24 0.23 0.26 0.27 0.32
Revenue Per Share
 80.00 46.70 41.31 52.65 50.67
Net Income Per Share
 7.86 10.45 11.80 16.16 17.83
Tax Burden
 0.84 0.78 0.74 0.73 0.68
Interest Burden
 0.83 1.05 0.98 0.98 1.05
Research & Development to Revenue
 0.00 0.00 0.00 <0.01 <0.01
SG&A to Revenue
 0.11 0.21 0.13 0.01 0.01
Stock-Based Compensation to Revenue
 0.01 0.01 <0.01 0.00 0.00
Income Quality
 0.88 0.84 1.19 0.81 0.49
Currency in INR